During the past decade, San Antonio Gastroenterology conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "San Antonio Gastroenterology" #1 sponsor was "Celgene" with 6 trials, followed by "Takeda" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "San Antonio Gastroenterology" are "Crohn's Disease" (4 trials), "Crohn Disease" (3 trials), "Ulcerative Colitis" (3 trials) and "Colitis, Ulcerative" (2 trials). Many other conditions were trialed in "San Antonio Gastroenterology" in a lesser frequency.

Most popular intervention types in "San Antonio Gastroenterology" are "Drug" (11 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Ozanimod" (4 trials), "RPC1063" (3 trials), "Apremilast" (1 trials) and "Mirikizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "San Antonio Gastroenterology" are 11 trials for "All" genders.

Currently, there are NaN active trials in "San Antonio Gastroenterology". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in San Antonio Gastroenterology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in San Antonio Gastroenterology, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".